acomplia diet pill acomplia rimonabant drug

acomplia rimonabant zimulti Information .


Blog For Free!


Archives
Home
2006 October
2006 August
2006 July
2006 June
2006 May

My Links
acomplia
sanofi

tBlog
My Profile
Send tMail
My tFriends
My Images


Sponsored
Blog




Reinstate your natural body shape with Zimulti
08.31.06 (6:44 am)   [edit]
Obesity has entrapped young and old alike in its web. Modern day luxuries have made situation worse. Obesity is associated with other health related issues such as cardiovascular diseases, Type-2 diabetes amongst others. You can break-free from the whirlpool of these health related risks with Zimulti (Acomplia).

The fast-paced life of the contemporary world has proven to be a root cause for many health hazards. Obesity constitutes one of them. Obesity in simple terms is a dietary disorder. It can be a consequence of various factors such as faulty life style, genetics, psychological factors, metabolic, high-calorific nutrition, neuroendocrines, medicament. A person would be considered obese if he or she has a Body Mass Index (BMI) greater than 30, as a consequence of over-consumption of fatty foods.

Your overweight can pull down your self-confidence and in turn affecting your personality. It can ruin some of your most cherished dreams such as wearing that sexy evening gown you saw at the mall. Not only that, it can make you a target of embarrassment among friends and relatives. In such a scenario, Zimulti can come to your rescue.

A French pharmaceutical company, Sanofi-Aventis has developed this wonder drug. Zimulti in essence is a brand name for Rimonabant. It is an oral-prescription drug, with Rimonabant as the active ingredient.

Zimulti is a promising weight loss drug, which acts as an appetite suppressant. It basically obstructs the CB-1 receptors, which regulate food and tobacco consumption. This makes you eat less than your normal appetite. Zimulti also has the potential to curb the unhealthy craving of tobacco, apart from weight loss. It reflects other benefits as well such as improvement in cholesterol, and metabolism-health related problems.

A diet pill alone cannot do wonders. Therefore, Zimulti should be used in combination with a balanced low calorie diet and regular workouts. The market is swamped with other alternatives to Zimulti such as Adipex, Orlistat (Xenical), Bontril, Didrex, Diethylpropion, Sibutramine (Meridia), Ionamin, Phendimetrazine, Tenuate as well. Yet, Zimulti has gained much popularity due to its optimistic results. A prior consultation with a doctor is recommended, before you go ahead with Zimulti treatment.

Zimulti will soon hit the US market. The availability of the much-awaited Zimulti diet drug can pave an easy way out for many Americans, to get in shape without a lot of hassle. Make a smart move and revolutionize the entire outlook of your body with Zimulti.

Summary


Zimulti is a brand name for Rimonabant, which was discovered and developed by a French pharmaceutical company Sanofi-Aventis. It an ideal way out to get rid of those extra pounds with ease.
Source:http://www.zimultiacompliaonline.com" title="http://www.zimultiacompliaonline.com" target="_blank"http://www.zimultiacompliaonl...

 
Sanofi Aventis : Acomplia en vente au Royaume-Uni
08.02.06 (6:52 am)   [edit]
Tuesday, July 18, 2006 55,20 livres, soit 80 euros environ, c'est ce qu'il faudra débourser au Royaume-Uni pour un mois de traitement par Acomplia. La tant attendue pilule de Sanofi Aventis destinée à contribuer à l'amincissement chez les patients obèses ou en surpoids présentant des facteurs de risque cardiométabolique associés. Acomplia doit bien évidemment être prescrit en accompagnement d'un régime adapté.Les patients britanniques seront donc les premiers à pouvoir obtenir ce médicament, le lancement dans les autres pays d'Europe étant appelé à s'échelonner sur les prochains mois. Le groupe pharmaceutique a organisé hier un point presse, n'hésitant pas à inviter des praticiens spécialistes (endocrinologue et cardiologues) pour donner le point de vue des prescripteurs. Un garde-fou bienvenu de la part de Sanofi Aventis qui ne veut en aucun cas que sa molécule ne soit assimilée à un médicament miracle.Au contraire, depuis le début, Sanofi rejette en bloc toute approche "cosmétique" en visant exclusivement les patients souffrant de réels troubles métaboliques, et non les personnes désirant simplement perdre du poids. Même ainsi restreint, le marché est du reste suffisamment vaste !Ainsi les prescripteurs éventuels invités à s'exprimer par Sanofi Aventis ont indiqué qu'ils ne coucheraient pas Acomplia sur l'ordonnance dès la première consultation d'un patient. La plupart attendraient plusieurs mois pour voir si un régime spécifique et la reprise d'une activité physique adaptée ne permettent pas à eux seuls d'améliorer l'état de santé du patient.
Source:- http://www.boursier.com/vals/...